People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Medical Devices, Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Click Diagnostics, Inc. | — | Medical Devices | Series D+ | $235.0M | $2.0B | 2015 |
| Cardiodx Inc | — | Biotechnology | Series C | $174.0M | $742.4M | 2012 |
| Chronus Health, Inc. | — | Healthtech | Series B | $26.6M | $17.2M | 2024 |
| Onconetix, Inc. | — | Biotechnology | Series A | $22.0M | $37.7M | 2024 |
| Bioimagene Inc | — | Biotechnology | Series A | $12.0M | $433.8M | 2009 |
Ajit Singh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ajit Singh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brook Byers | 1 | 13 |
| Michael Goldberg | 1 | 11 |
| Patrick Enright | 1 | 10 |
| Risa Stack | 1 | 9 |
| James Sapirstein | 1 | 7 |
| Patrick G. Enright | 1 | 7 |
| G. Steven Burrill | 1 | 7 |
| Yatin Mundkur | 1 | 7 |
| William Ericson | 1 | 6 |
| James R. Tobin | 1 | 6 |
| John Dean | 1 | 5 |
| Rishi Reddy | 1 | 4 |
| Thomas M. Prescott | 1 | 4 |
| Louis G. Lange | 1 | 4 |
| Joseph Keegan | 1 | 4 |
| Fred G. Cohen | 1 | 3 |
| Brook H Byers | 1 | 3 |
| David Levison | 1 | 3 |
| Arthur M. Pappas | 1 | 3 |
| Shlomo Melmed | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.